Impact of rheumatoid arthritis on receiving a diagnosis of hypertension among patients with regular primary care

Arthritis Care and Research

Volumn 66, Issue 9, 2014, Pages 1281-1288

  Bartels, Christie M ^a   Johnson, Heather ^a   Voelker, Katya ^a   Thorpe, Carolyn ^b   McBride, Patrick ^a   Jacobs, Elizabeth A ^a   Pandhi, Nancy ^a   Smith, Maureen ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; ELEVATED BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; ICD-9; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREDICTOR VARIABLE; PRESCRIPTION; PRIMARY MEDICAL CARE; RHEUMATOID ARTHRITIS; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; RISK FACTORS; YOUNG ADULT;

EID: 84906690476     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22302     Document Type: Article

References (48)

1. Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D,. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 2008; 59: 1690-7.
2. Meune C, Touze E, Trinquart L, Allanore Y,. Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 2009; 48: 1309-13.
3. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, et al. Explaining the decrease in US deaths from coronary disease, 1980-2000. N Engl J Med 2007; 356: 2388-98.
4. Gonzalez A, Maradit Kremers H, Crowson CS, Nicola PJ, Davis JM III, Therneau TM, et al. The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum 2007; 56: 3583-7.
5. Bartels CM, Kind AJ, Everett C, Mell M, McBride P, Smith M,. Low frequency of primary lipid screening among Medicare patients with rheumatoid arthritis. Arthritis Rheum 2011; 63: 1221-30.
6. Bartels CM, Kind AJ, Thorpe CT, Everett CM, Cook RJ, McBride PE, et al. Lipid testing in patients with rheumatoid arthritis and key cardiovascular- related comorbidities: a Medicare analysis. Semin Arthritis Rheum 2012; 42: 9-16.
7. Innala L, Moller B, Ljung L, Magnusson S, Smedby T, Sodergren A, et al. Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study. Arthritis Res Ther 2011; 13: R131.
8. Serelis J, Panagiotakos DB, Mavrommati M, Skopouli FN,. Cardiovascular disease is related to hypertension in patients with rheumatoid arthritis: a Greek cohort study. J Rheumatol 2011; 38: 236-41.
9. Panoulas VF, Metsios GS, Pace AV, John H, Treharne GJ, Banks MJ, et al. Hypertension in rheumatoid arthritis. Rheumatology (Oxford) 2008; 47: 1286-98.
10. Bild DE, Detrano R, Peterson D, Guerci A, Liu K, Shahar E, et al. Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2005; 111: 1313-20.
11. Chung CP, Giles JT, Petri M, Szklo M, Post W, Blumenthal RS, et al. Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis. Semin Arthritis Rheum 2012; 41: 535-44.
12. Crowson CS, Matteson EL, Roger VL, Therneau TM, Gabriel SE,. Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. Am J Cardiol 2012; 110: 420-4.
13. Crowson CS, Nicola PJ, Maradit Kremers H, O'Fallon WM, Therneau TM, Jacobsen SJ, et al. How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease? Arthritis Rheum 2005; 52: 3039-44.
14. Dessein PH, Joffe BI, Veller MG, Stevens BA, Tobias M, Reddi K, et al. Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis. J Rheumatol 2005; 32: 435-42.
15. Panoulas VF, Douglas KM, Milionis HJ, Stavropoulos-Kalinglou A, Nightingale P, Kita MD, et al. Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology (Oxford) 2007; 46: 1477-82.
16. Solomon DH, Kremer J, Curtis JR, Hochberg MC, Reed G, Tsao P, et al. Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity. Ann Rheum Dis 2010; 69: 1920-5.
17. Soubrier M, Zerkak D, Dougados M,. Indications for lowering LDL cholesterol in rheumatoid arthritis: an unrecognized problem. J Rheumatol 2006; 33: 1766-9.
18. Thorpe CT, Flood GE, Kraft SA, Everett CM, Smith MA,. Effect of patient selection method on provider group performance estimates. Med Care 2011; 49: 780-5.
19. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-72.
20. Tu K, Campbell NR, Chen ZL, Cauch-Dudek KJ, McAlister FA,. Accuracy of administrative databases in identifying patients with hypertension. Open Med 2007; 1: e18-26.
21. Hansen ML, Gunn PW, Kaelber DC,. Underdiagnosis of hypertension in children and adolescents. JAMA 2007; 298: 874-9.
22. MacLean CH, Louie R, Leake B, McCaffrey DF, Paulus HE, Brook RH, et al. Quality of care for patients with rheumatoid arthritis. JAMA 2000; 284: 984-92.
23. Hebert PL, Geiss LS, Tierney EF, Engelgau MM, Yawn BP, McBean AM,. Identifying persons with diabetes using Medicare claims data. Am J Med Qual 1999; 14: 270-7.
24. Foley RN, Murray AM, Li S, Herzog CA, McBean AM, Eggers PW, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 2005; 16: 489-95.
25. Chronic condition reference list. Warrenton (VA): Buccaneer Computer Systems and Services; 2011. URL: http://www.ccwdata.org/cs/groups/public/ documents/document/ccw-conditionreferencelist2011.pdf.
26. Borzecki AM, Wong AT, Hickey EC, Ash AS, Berlowitz DR,. Identifying hypertension-related comorbidities from administrative data: what's the optimal approach? Am J Med Qual 2004; 19: 201-6.
27. Newton KM, Wagner EH, Ramsey SD, McCulloch D, Evans R, Sandhu N, et al. The use of automated data to identify complications and comorbidities of diabetes: a validation study. J Clin Epidemiol 1999; 52: 199-207.
28. Marciniak MD, Lage MJ, Dunayevich E, Russell JM, Bowman L, Landbloom RP, et al. The cost of treating anxiety: the medical and demographic correlates that impact total medical costs. Depress Anxiety 2005; 21: 178-84.
29. Elixhauser A, Steiner C, Harris DR, Coffey RM,. Comorbidity measures for use with administrative data. Med Care 1998; 36: 8-27.
30. Reid RJ, Roos NP, MacWilliam L, Frohlich N, Black C,. Assessing population health care need using a claims-based ACG morbidity measure: a validation analysis in the province of Manitoba. Health Serv Res 2002; 37: 1345-64.
31. Pham HH, Schrag D, Hargraves JL, Bach PB,. Delivery of preventive services to older adults by primary care physicians. JAMA 2005; 294: 473-81.
32. StataCorp. Stata statistical software: release 12. College Station (TX): StataCorp; 2011.
33. Piette JD, Kerr EA,. The impact of comorbid chronic conditions on diabetes care. Diabetes Care 2006; 29: 725-31.
34. Nguyen-Oghalai TU, Hunnicutt SE, Smith ST, Maganti R, McNearney TA,. Factors that impact decision making among rheumatologists in the initiation of treatment for hypertension in rheumatoid arthritis. J Clin Rheumatol 2007; 13: 307-12.
35. Symmons DP, Gabriel SE,. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol 2011; 7: 399-408.
36. Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010; 69: 325-31.
37. Yazdany J, Panopalis P, Gillis JZ, Schmajuk G, MacLean CH, Wofsy D, et al. A quality indicator set for systemic lupus erythematosus. Arthritis Rheum 2009; 61: 370-7.
38. Yazdany J, Trupin L, Tonner C, Dudley RA, Zell J, Panopalis P, et al. Quality of care in systemic lupus erythematosus: application of quality measures to understand gaps in care. J Gen Intern Med 2012; 27: 1326-33.
39. Bell C, Rowe IF,. The recognition and assessment of cardiovascular risk in people with rheumatoid arthritis in primary care: a questionnaire-based study of general practitioners. Musculoskeletal Care 2011; 9: 69-74.
40. Desai SS, Myles JD, Kaplan MJ,. Suboptimal cardiovascular risk factor identification and management in patients with rheumatoid arthritis: a cohort analysis. Arthritis Res Ther 2012; 14: R270.
41. Jopp DA, Keys CB,. Diagnostic overshadowing reviewed and reconsidered. Am J Ment Retard 2001; 106: 416-33.
42. Fisher ES, McClellan MB, Bertko J, Lieberman SM, Lee JJ, Lewis JL, et al. Fostering accountable health care: moving forward in Medicare. Health Aff (Millwood) 2009; 28: w219-31.
43. Carrier E, Dowling MK, Pham HH,. Care coordination agreements: barriers, facilitators, and lessons learned. Am J Manag Care 2012; 18: e398-404.
44. Feldman RD, Zou GY, Vandervoort MK, Wong CJ, Nelson SA, Feagan BG,. A simplified approach to the treatment of uncomplicated hypertension: a cluster randomized, controlled trial. Hypertension 2009; 53: 646-53.
45. Gomez-Vaquero C, Robustillo M, Narvaez J, Rodriguez-Moreno J, Gonzalez-Juanatey C, Llorca J, et al. Assessment of cardiovascular risk in rheumatoid arthritis: impact of the new EULAR recommendations on the score cardiovascular risk index. Clin Rheumatol 2012; 31: 35-9.
46. Primdahl J, Clausen J, Horslev-Petersen K,. Results from systematic screening for cardiovascular risk in outpatients with rheumatoid arthritis in accordance with the EULAR recommendations. Ann Rheum Dis 2013; 72: 1771-6.
47. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
48. Katz JN, Barrett J, Liang MH, Bacon AM, Kaplan H, Kieval RI, et al. Sensitivity and positive predictive value of Medicare Part B physician claims for rheumatologic diagnoses and procedures. Arthritis Rheum 1997; 40: 1594-600.